Tempus AI (NASDAQ:TEM) Trading Up 4.2% - Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price was up 4.2% during trading on Tuesday . The stock traded as high as $47.23 and last traded at $47.08. Approximately 3,436,270 shares were traded during mid-day trading, a decline of 28% from the average daily volume of 4,804,807 shares. The stock had previously closed at $45.17.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on TEM shares. Morgan Stanley upped their price target on Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and upped their price target for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Loop Capital dropped their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. Wolfe Research cut Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, William Blair reissued a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $61.18.

Tempus AI Stock Down 0.2 %

The stock has a fifty day moving average of $54.76 and a two-hundred day moving average of $52.03. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Remove Ads

Insider Activity at Tempus AI

In related news, CAO Ryan M. Bartolucci sold 13,770 shares of the firm's stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the completion of the sale, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at $3,434,220. This trade represents a 19.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bradley A. Keywell sold 170,720 shares of the firm's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total value of $6,052,024.00. Following the sale, the insider now directly owns 15,993,729 shares of the company's stock, valued at $566,977,693.05. This represents a 1.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,755,906 shares of company stock valued at $322,788,693 in the last three months.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of TEM. Operose Advisors LLC bought a new position in Tempus AI in the 4th quarter valued at $25,000. First Horizon Advisors Inc. bought a new position in Tempus AI in the 3rd quarter valued at $30,000. Farther Finance Advisors LLC bought a new position in Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC boosted its position in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after buying an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new position in Tempus AI in the 4th quarter valued at $49,000. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.